CytomX Therapeutics, Inc. (CTMX) Revenue 2016–2025
CytomX Therapeutics, Inc. (CTMX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$76.2MFY2025 · since FY2016: $12.8M → $76.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $76.2M | -44.8% |
| FY2024 | $138.1M | +36.4% |
| FY2023 | $101.2M | +90.4% |
| FY2022 | $53.2M | +42.5% |
| FY2021 | $37.3M | -45.5% |
| FY2020 | $68.4M | +154.4% |
| FY2019 | $26.9M | -54.8% |
| FY2018 | $59.5M | -16.9% |
| FY2017 | $71.6M | +457.6% |
| FY2016 | $12.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice